Defi Technologies (NASDAQ:DEFT - Free Report) had its target price increased by Maxim Group from $6.50 to $7.00 in a research report report published on Tuesday,Benzinga reports. The firm currently has a buy rating on the stock.
Separately, HC Wainwright boosted their price objective on Defi Technologies from $4.50 to $5.50 and gave the company a "buy" rating in a research report on Thursday, May 15th.
Read Our Latest Report on Defi Technologies
Defi Technologies Stock Down 8.3%
Shares of DEFT stock traded down $0.31 during trading hours on Tuesday, reaching $3.43. 3,269,158 shares of the company's stock were exchanged, compared to its average volume of 1,128,269. Defi Technologies has a fifty-two week low of $0.77 and a fifty-two week high of $4.95. The firm has a market cap of $1.12 billion and a PE ratio of 11.83.
About Defi Technologies
(
Get Free Report)
DeFi Technologies, Inc engages in the provision of investment services. It plans to acquire equity, debt, or other securities of publicly traded or private companies or other entities. The firm offers DeFi ETNs, DeFi Governance, DeFi Venture and DeFi Treasury. The company was founded by Olivier Francois Roussy Newton and Wouter Witvoet on April 14, 1986 and is headquartered in Toronto, Canada.
See Also
Before you consider Defi Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Defi Technologies wasn't on the list.
While Defi Technologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.